Hui Gao
Changzhi Medical College(CN)
Publications by Year
Research Areas
Cancer Cells and Metastasis, Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery, Cancer Immunotherapy and Biomarkers, Estrogen and related hormone effects
Most-Cited Works
- → High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response(2015)1,424 cited
- → Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases(2016)909 cited
- → Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5(2016)552 cited
- → Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials(2014)491 cited
- → Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia(2008)398 cited
- → The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival(2017)350 cited
- → Quasi-Molecular Fluorescence from Graphene Oxide(2011)307 cited
- → The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice(2016)302 cited
- → Highly Efficient Far Red/Near‐Infrared Solid Fluorophores: Aggregation‐Induced Emission, Intramolecular Charge Transfer, Twisted Molecular Conformation, and Bioimaging Applications(2015)296 cited
- → Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials(2022)205 cited